Department of Surgery, Saiseikai Yokohamashi Nanbu Hospital, Yokohama, Japan
Department of Surgery, Saiseikai Yokohamashi Nanbu Hospital, Yokohama, Japan.
In Vivo. 2020 Nov-Dec;34(6):3661-3667. doi: 10.21873/invivo.12213.
BACKGROUND/AIM: The current study aimed to identify the safety and efficacy of Hartmann's procedure (HP) among elderly patients (age ≥80 years) with rectal cancer.
Data on surgical outcome, survival rate, and incidence of stoma reversal were retrospectively compared between patients aged over 80 years who underwent anterior resection (AR) and HP.
In total, 79 elderly patients underwent rectal cancer surgery. Of these patients, 54 (68.4%) underwent AR and 25 (31.6%) HP. The two groups did not differ significantly in terms of age, nutrient status, and tumor characteristics. Eight (14.8%) patients who underwent AR and six (24.0%) who underwent HP presented with intra-abdominal complications (p=0.35). The overall survival and recurrent-free survival rates between the two groups did not differ.
HP for elderly patients with rectal cancer has similar complication rates to AR, and achieved similar oncological outcomes.
背景/目的：本研究旨在确定高龄（≥80 岁）直肠癌患者行Hartmann 手术（HP）的安全性和有效性。
回顾性比较了年龄>80 岁行直肠前切除术（AR）和 HP 的患者的手术结果、生存率和造口逆转发生率。
共 79 例老年直肠癌患者接受手术治疗。其中 54 例（68.4%）行 AR，25 例（31.6%）行 HP。两组在年龄、营养状况和肿瘤特征方面无显著差异。行 AR 的 8 例（14.8%）和行 HP 的 6 例（24.0%）患者出现腹腔内并发症（p=0.35）。两组的总生存率和无复发生存率无差异。
HP 治疗高龄直肠癌患者的并发症发生率与 AR 相似，且具有相似的肿瘤学疗效。
